Additional Professor, Department of Microbiology, AIIMS, Bhopal, Madhya Pradesh, India.
Senior Research Fellow, Department of Microbiology, AIIMS, Bhopal, Madhya Pradesh, India.
Indian J Public Health. 2024 Apr 1;68(2):163-166. doi: 10.4103/ijph.ijph_1098_23. Epub 2024 Jun 29.
Several sporadic cases and outbreaks of Zika virus disease have been reported from different states of India.
This paper explored the possibility of any ongoing transmission of Zika virus (ZIKV) in the Bhopal region of Central India, where the last outbreak of this disease was reported in 2018.
We screened a group of 75 febrile patients who had already tested negative for the locally endemic causes of fever like dengue, chikungunya, enteric fever, malaria, and scrub typhus and two groups of asymptomatic healthy individuals represented by blood donors (n = 75) and antenatal mothers (n = 75). We tested blood samples of febrile patients for ZIKV RNA using real-time polymerase chain reaction (PCR), and for the healthy individuals, we determined anti-zika immunoglobulin G (IgG) antibodies using enzyme-linked immunosorbent assay.
ZIKV RNA was not detected in any of the 75 samples tested by real-time PCR assay. Among the voluntary blood donors and antenatal mothers, a total of 10 (15.38%) and 5 (6.66%) individuals were found to be seropositive for anti-ZIKV IgG antibodies, respectively. The seropositive group was found to have higher age 33.06 (±10.83) years as compared to seronegative individuals 26.60 (±5.12) years (P = 0.037).
This study, which is the first survey of seroprevalence of anti-Zika antibodies from India, reports an overall seropositivity rate of 10% for anti-Zika antibodies among the healthy population, suggesting an ongoing, low level, silent transmission of ZIKV in the local community.
印度不同邦已报告了几例散发性寨卡病毒病病例和暴发。
本文探讨了在印度中央邦博帕尔地区是否存在寨卡病毒(ZIKV)持续传播的可能性,该地区曾于 2018 年报告过该病的最后一次暴发。
我们筛查了一组 75 名发热患者,这些患者已针对地方性发热病因(如登革热、基孔肯雅热、肠热病、疟疾和丛林斑疹伤寒)进行了检测且结果均为阴性,另外还包括两组无症状的健康个体,一组为献血者(n=75),另一组为产前孕妇(n=75)。我们使用实时聚合酶链反应(PCR)检测发热患者的血液样本中的 ZIKV RNA,并使用酶联免疫吸附试验检测健康个体的抗寨卡 IgG 抗体。
实时 PCR 检测未在任何 75 份检测样本中检测到 ZIKV RNA。在自愿献血者和产前孕妇中,共有 10(15.38%)和 5(6.66%)人抗 ZIKV IgG 抗体检测结果呈阳性。与血清阴性个体(26.60±5.12 岁)相比,血清阳性组的年龄更大(33.06±10.83 岁)(P=0.037)。
这项研究是印度首次对寨卡抗体血清流行率进行的调查,报告称在健康人群中抗寨卡抗体的总体阳性率为 10%,表明 ZIKV 在当地社区中存在持续、低水平、隐性传播。